WallStSmart

Churchill Capital Corp XI (CCXI)vsHaymaker Acquisition Corp. 4 (HYAC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HYAC leads profitability with a 0.0% profit margin vs 0.0%. HYAC earns a higher WallStSmart Score of 27/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

HYAC

Avoid

27

out of 100

Grade: F

Growth: 3.7Profit: 3.5Value: 5.0Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

HYAC0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$805.98M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

HYAC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$313.64M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : HYAC

HYAC has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : HYAC

The primary concerns for HYAC are Revenue Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

HYAC is growing revenue faster at 0.0% — sustainability is the question.

HYAC generates stronger free cash flow (6M), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HYAC scores higher overall (27/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Haymaker Acquisition Corp. 4

FINANCIAL SERVICES · SHELL COMPANIES · USA

Haymaker Acquisition Corp. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?